LONN CH0013841017

Report

Real-time Estimate Cboe Europe - 11/29 10:58:07 am
733.2	CHF		-0.73%

01:33a	Oxford BioMedica, Lonza, Fujifilm Eye UK's Vaccine Manufacturing Innovation Center	MT
11/17	Lonza Agrees to Manufacture Bluejay's Lead Antibody Candidate For Chronic Hepatitis B Virus	MT
11/17	GLOBAL MARKETS LIVE : Tesla, Experian, Roche, Activision, Amazon...	AX

Summary

Quotes 5-day view Delayed Quote.

Delayed Swiss Exchange

11/23/2021	11/24/2021	11/25/2021	11/26/2021	11/29/2021	Date
707.4(c)	702.8(c)	716.4(c)	738.6(c)	732.8	Last
209 164	192 046	101 127	246 203	84 909	Volume
-4.69%	-0.65%	+1.94%	+3.10%	-0.79%	Change

More quotes

Estimated financial data (e)

Sales 2021	5 174 M 5 591 M 5 591 M
Net income 2021	734 M 793 M 793 M
Net cash position 2021	569 M 615 M 615 M
P/E ratio 2021	74,5x
Yield 2021	0,41%

Sales 2022	5 879 M 6 353 M 6 353 M
Net income 2022	1 052 M 1 137 M 1 137 M
Net cash position 2022	491 M 531 M 531 M
P/E ratio 2022	51,9x
Yield 2022	0,45%

Capitalization	54 865 M 59 443 M 59 287 M
EV / Sales 2021	10,5x
EV / Sales 2022	9,25x
Nbr of Employees	14 405
Free-Float	99,7%

More Financials

Company

Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The Company divides its activities into two segments: Pharma&Biotech and Specialty Ingredients.

Sector

Biotechnology & Medical Research

Calendar

01/26

Earnings Release

More about the company

Ratings of Lonza Group AG

Trading Rating :

Investor Rating :

ESG Refinitiv :

A-

More Ratings

All news about LONZA GROUP AG

01:33a	Oxford BioMedica, Lonza, Fujifilm Eye UK's Vaccine Manufacturing Innovation Center	MT
11/17	Lonza Agrees to Manufacture Bluejay's Lead Antibody Candidate For Chronic Hepatitis B V..	MT
11/17	GLOBAL MARKETS LIVE : Tesla, Experian, Roche, Activision, Amazon...	AX
11/17	LONZA : and BlueJay Therapeutics Announce Manufacturing Agreement for its Antibody BJT-778..	PU
11/16	Lonza to Boost Microbial Development Lab Capabilities at Swiss Site	MT
11/16	LONZA : to Expand Microbial Development Laboratories	PU
11/10	Lonza JV Bacthera, Seres to Jointly Produce Potential Gut Infection Treatment	MT
11/05	Cepsa explores chemicals sale to fund clean energy push - sources	RE
11/04	AlphaValue/Baader Europe Lifts Price Target on Lonza Group, Maintains Sell Recommendati..	MT
11/02	Lonza to Buy Service Unit of Exosomics	MT
11/02	Lonza Group to Purchase Specialized Manufacturing Plant From Codiak BioSciences	MT
11/02	Lonza to Acquire Service Unit in Italy, Manufacturing Facility in US	DJ
11/02	Lonza to Acquire Codiak BioSciences Exosome Manufacturing Plant	DJ
11/02	Lonza to Acquire Exosomics Service Unit to Expand Exosomes Service Offering	PU
11/02	Lonza Group Ltd agreed to acquire Service unit from Exosomics Siena S.p.A.	CI

More news

News in other languages on LONZA GROUP AG

11/26	Aktien Schweiz knicken mit Corona-Ängsten ein - Logitech und Lonza fester
11/26	Reise- und Luxusaktien gehen vor neuem Virus in die Knie
11/24	Aktien Schweiz zur Wochenmitte mit moderaten Aufschlägen
11/23	Aktien Schweiz schließen schwach - Partners Group sacken ab
11/19	Aktien Schweiz schließen knapp behauptet - Logitech fest

More news

Analyst Recommendations on LONZA GROUP AG

11/04	AlphaValue/Baader Europe Lifts Price Target on Lonza Group, Maintains Sell Recommendati..	MT
10/19	LONZA : Berenberg Lifts Price Target on Lonza Group, Maintains Buy Recommendation	MT
10/15	LONZA : Deutsche Bank Lifts Price Target on Lonza Group, Maintains Buy Recommendation	MT

More recommendations

Provided by Scoopnest.com

Analysis

Lonza : invests in new production line in China